Letter to the editor: Concerning the paper entitled "TC (Giloy) induced liver injury…" by Anand Kulkarni et al

Affiliations

Comment

Sreejith Narayanan Edamana et al. Hepatol Commun. 2022 Aug.

. 2022 Aug;6(8):2221-2222.

doi: 10.1002/hep4.1978. Epub 2022 May 3.

No abstract available

Conflict of interest statement

R.V. owns stock in and is an employee of Kerala First Health Services Pvt. Ltd.

Tinospora Cordifolia (Giloy)-Induced Liver Injury During the COVID-19 Pandemic-Multicenter Nationwide Study From India.
Kulkarni AV, Hanchanale P, Prakash V, Kalal C, Sharma M, Kumar K, Bishnu S, Kulkarni AV, Anand L, Patwa AK, Kumbar S, Kainth S, Philips CA; Liver Research Club India. Kulkarni AV, et al. Hepatol Commun. 2022 Jun;6(6):1289-1300. doi: 10.1002/hep4.1904. Epub 2022 Feb 6. Hepatol Commun. 2022. PMID: 35037744 Free PMC article.

1. Kulkarni AV, Hanchanale P, Prakash V, Kalal C, Sharma M, Kumar K, et al.; for the Liver Research Club India . Tinospora cordifolia (Giloy) induced liver injury during the Covid‐19 pandemic—multicenter nationwide study from India. Hepatol Commun. 2022. Jan 17. 10.1002/hep4.1904. [Epub ahead of print] - DOI - PMC - PubMed
1. Peláez D, Fernández H, Regino W. Emerging concepts: herb‐induced liver injury (HILI). Rev Colomb Gastroenterol. 2019;34:56–62.
1. Danan G, Teschke R. RUCAM in drug and herb induced liver injury: the update. Int J Mol Sci. 2016;17:14. - PMC - PubMed
1. Kuna L, Bozic I, Kizivat T, Bojanic K, Mrso M, Kralj E, et al. Models of drug induced liver injury (DILI)—current issues and future perspectives. Curr Drug Metab. 2018;19:830–8. - PMC - PubMed
1. Tofthagen C. Threats to validity in retrospective studies. J Adv Pract Oncol. 2012;3:181–3. - PMC - PubMed